Tvardi Therapeutics (TVRD) Q3 2025 Earnings

14AugConfirmed
Q1 2025
Q2 2025
Q3 2025
-7.08
-4.92
-2.75
-0.59

Details

Expected EPS
-0.683067
Actual EPS
-1
Surprise EPS
-0.32
Surprise Percent
+46.4%

Description

Tvardi Therapeutics (TVRD) has reported earnings of -1 per share for Q3 2025.

0 Comments

Share your thoughts